This was a singlecenter, interventional, openlabel, proofofconcept study where 24 patients with AT were treated with NR (25 mg/kg bodyweight per day) during four consecutive months and subsequently followed during 2 months without treatment
Standardized outcome measurement facilitates assessment of individual patient response and contributes to broader understanding of clinical efficacy
however, it is prepared in accordance with current good manufacturing practices and quality standards applicable to outsourcing facilities
For research protocols that require multiple accesses to a vial, bacteriostatic water is strongly preferred
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial